Inovalon Holdings IPO Research Information

Inovalon Holdings IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Inovalon Holdings, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Inovalon Holdings	INOV - NASDAQ	$21.00-$24.00	$27.00	$33.16	22.2 million	2/12/2015
Underwriter(s): Goldman Sachs & Co., Morgan Stanley, Citigroup, BofA Merrill Lynch, UBS Investment Bank
Co-Manager(s): Baird, Piper Jaffray, Wells Fargo Securities, William Blair
Industry: Technology
Filing(s): FIled 2014-12-30 Terms Added 2015-01-29 Amended Terms 2015-02-10

Inovalon Holdings Quote & Chart - Click for current quote - INOV

About Inovalon Holdings (adapted from Inovalon Holdings prospectus):
They are a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and improvement in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "INOV" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.